Argus Research Maintains Buy on Huntington Bancshares, Lowers Price Target to $18
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsPrice Target
Argus Research analyst Kevin Heal maintains Huntington Bancshares (NASDAQ:HBAN) with a Buy and lowers the price target from $20 to $18.
Argus Research analyst Kevin Heal maintains Huntington Bancshares (NASDAQ:HBAN) with a Buy and lowers the price target from $20 to $18.